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CASE PRESENTATION
A Caucasian girl, the product of a non-consanguineous
union, was delivered after a full-term uneventful
pregnancy with a birth weight of 4.1 kg. At 15 months, she
presented to the emergency room with signs of a
respiratory illness and was found to weigh 6.14 kg, below
the 3rd percentile for age. She had no history of fevers,
dehydration, or photophobia and there was no family
history of renal or other medical disease. The patient had
one elder sister who had no medical complaints. Physical
examination revealed a fair-haired blue-eyed child with
pale complexion. Details of her ethnic ancestry were
unknown. Blood pressure was normal and the remainder
of the physical examination was also unremarkable.
Laboratory investigations at 15 months revealed blood
urea nitrogen 9 mg per 100 ml (normal range (N)¼ 8–25),
serum creatinine 0.6 mg per 100 ml (estimated creatinine
clearance o60 ml min1), serum sodium 133 mmol l1
(N¼ 136–145), potassium 3 mmol l1 (N¼ 3.5–5.5), chloride
105 mmol l1 (N¼ 96–106 mEq l1), total carbon dioxide
(CO2) 18.7 mEq l
1 (N¼ 22–30), serum calcium 10.6 mg per
100 ml (N¼ 8.5–10.6 mg per 100 ml), and phosphate
3.4 mg per 100 ml (N¼ 2.5–4.6). Arterial blood gas was not
drawn. Urinalysis revealed specific gravity o1.005, no
protein or cells, and trace glycosuria. However, there was
no evidence of phosphaturia (24 h urinary phosphorous
excretion 0.2 mmol, N¼ 0.4–1.3), hypercalciuria, or
increased urinary organic acid excretion. Measurement of
urinary amino acids was not performed. Hematologic
parameters and thyroid function tests, including thyroid
stimulating hormone, T4, and free T4, were within
normal limits. Based on the finding of hypokalemia, an
investigation for possible Bartter’s syndrome was
undertaken. These tests revealed markedly elevated
plasma levels of renin (119 853 ng per 100 ml
per h, N¼ 171–115) and aldosterone (715 ng per
100 ml, N¼ 3–35) that, together with the findings of
normal blood pressure, hypokalemia, and hyponatremia,
suggested a diagnosis of acquired Bartter’s syndrome.
The patient was treated for the next two and a half
years with indomethacin and electrolyte replacement,
including potassium chloride and calcium carbonate.
During this time, she gained weight and normalization
of blood electrolytes. However, at 4 years of age, she was
noted to have worsening renal insufficiency (serum
creatinine 1.2–1.4 mg per 100 ml) and 4þ proteinuria on
dipstick. At this time, an elevated thyroid stimulating
hormone was noted (17.27 IU ml1, N¼ 0.3–5.0), indicating
hypothyroidism, and thyroid replacement therapy was
commenced. Indomethacin was discontinued but renal
function and proteinuria continued to deteriorate over the
following year. At age 5 years, serum creatinine was
2.9 mg per 100 ml, urinary protein excretion was 1.8 g per
24 h, serum albumin was 3.4 g per 100 ml (normal42.5 g
per 100 ml), and blood pressure was 80/50 mm Hg. A renal
biopsy was performed.
RENAL BIOPSY
By light microscopy, there were 97 glomeruli, 78 of which
showed complete or near-complete global sclerosis and 7 of
which showed segmental obliteration of capillary lumens by
sclerosis and hyalinosis. Most of the non-sclerotic glomeruli
displayed occasional multinucleated visceral and parietal
epithelial cells, without associated endocapillary hypercellu-
larity or crescent formation (Figures 1–3). The multi-
nucleated visceral epithelial cells expressed vimentin and
CD10, but were CD68 negative, consistent with a podocyte
origin. No mitotic figures or immunoperoxidase staining for Ki-
67 (a marker of cell proliferation) was seen in these cells. There
was focal prominence of the juxtaglomerular apparatus.
Moderate to severe tubular atrophy and interstitial fibrosis
affected 65% of the cortical area. Numerous interstitial CD68þ
histiocytes were seen (Figure 4). Arterial vessels showed mild to
moderate medial hypertrophy. Immunofluorescence micro-
scopy showed segmental glomerular tuft staining in 5 of 15
glomeruli for IgM, kappa and lambda, and no specific staining
for IgG, IgA, complement (C3 or C1q), fibrinogen, or albumin.
The tissue for immunofluorescence studies had been immersed
in Zeus fixative; thus, no unfixed cryostat tissue sections were
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available for examination under polarized light micros-
copy. However, toluidine blue-stained screening sections for
electron microscopy revealed numerous clear intracytoplasmic
clefts within interstitial cells, corresponding to the CD68þ
histiocytes seen in formalin-fixed tissue sections (Figure 5).
Ultrastructural examination demonstrated empty needle- and
rhomboid-shaped inclusions within these cells, some of which
were limited by a single membrane (Figure 6). No cytoplasmic
inclusions were seen in interstitial endothelial cells, tubular
epithelium, or arterial wall myocytes. However, the electron
microscopy tissue sample contained sclerotic glomeruli only,
precluding evaluation of glomerular cells.
DIAGNOSIS
The pathologic findings of chronic tubulo-interstitial nephro-
pathy with numerous multinucleated podocytes and cytoplasmic
crystalline inclusions within interstitial cells favored a
diagnosis of nephropathic cystinosis.
CLINICAL FOLLOW-UP
Following renal biopsy examination, testing performed in
peripheral blood leukocytes revealed markedly elevated
cystine levels (6.1 mmol ½ cystine per mg protein; control
o0.1 mmol ½ cystine per mg protein), confirming the
diagnosis of cystinosis. Ophthalmologic examination to
detect corneal crystals was not performed as the patient
had no visual symptoms. Treatment with cysteamine was
started immediately and the patient was listed for renal
transplantation.
DISCUSSION
Cystinosis is a rare autosomal recessive disease caused by
heritable mutations of the CTNS gene encoding cystinosin, a
lysosomal transport protein. Defective lysosomal transport
leads to widespread accumulation and crystallization of
cystine in many organs, notably kidney, cornea, bone
marrow, thyroid, lymph nodes, liver, and spleen.1 Renal
manifestations dominate the clinical presentation and course
in infantile nephropathic cystinosis, the most common and
severe phenotype (see Table 1). Other organs frequently
affected include the cornea and thyroid, causing painful
photophobia and hypothyroidism, respectively. A milder
cystinosis phenotype presents in adolescence with more
slowly progressive renal failure and ocular disease, and an
adult ocular (non-nephropathic) form manifests only corneal
disease, and never develops signs of renal or other organ
involvement.1 Infantile nephropathic cystinosis is associated
with two severe CTNS mutations, including deletions,
insertions, nonsense, missense, and splicing mutations,1 that
cause complete abolition of cystine transport. The adolescent
and ocular forms generally have one severe and one mild
mutation, leading to reduced transport. The sparing of the
kidney in cases of ocular cystinosis may reflect tissue-specific
expression of splicing factors, or the increased endogenous
level of CTNS mRNA normally seen in the kidney.2
Individuals who are heterozygous for severe CTNS mutations
demonstrate elevated levels of leukocyte cystine but are
completely asymptomatic.
Most patients with infantile nephropathic cystinosis
present during the first year of life with failure to thrive,
polyuria, polydipsia, and/or dehydration and are found to
have Fanconi’s syndrome with normal anion gap metabolic
acidosis.1 Some of these patients may develop vitamin D-
resistant rickets due to phosphaturia. Renal function is
generally normal at presentation, but without treatment most
individuals progress to end-stage renal disease after 5 years of
Figure 1 | Glomerulus with multiple multinucleated podocytes
and parietal epithelial cells (arrows) (hematoxylin and
eosin stain; original magnification  40).
Figure 2 | Periodic acid–Schiff (PAS) reaction demarcates the
glomerular basement membrane and highlights the visceral
and parietal epithelial location of the multinucleated cells
(arrows) (PAS; original magnification  40).
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age, and only rarely before then.3 The urine and serum
biochemical abnormalities in Fanconi’s syndrome, including
hyperchloremic metabolic acidosis, hypokalemia, hypopho-
sphatemia, glycosuria, aminoaciduria, and phosphaturia, are
consistent with a generalized defect in proximal tubular
transport.4 There have also been several reported cases of
nephropathic cystinosis presenting with features of secondary
Bartter’s syndrome (hypokalemia, hypochloremic metabolic
alkalosis, hyperreninemia, and hyperaldosteronism), suggest-
ing abnormalities of sodium and chloride reabsorption.5–11
Most of these cystinosis patients also had Fanconi’s syndrome
and, similar to the present case, several showed reversal of
Bartter’s syndrome following treatment with aspirin or
indomethacin, consistent with an acquired defect.7,8,10 Our
patient presented with an unusual constellation of abnor-
malities including glycosuria and metabolic acidosis, consistent
with partial Fanconi’s syndrome, as well as biochemical
features suggestive of acquired Bartter’s syndrome, including
hypokalemia, hyponatremia, normotensive hyperreninema,
and hyperaldosteronemia.
The pathophysiology of tubular transport defects in
cystinosis patients is poorly understood, reflecting the lack
of an animal model for this disease. Knockout mice lacking
cystinosin (CTNS/) do not develop signs of Fanconi’s
syndrome, despite accumulation of lysosomal cystine in
proximal tubules.12 Investigations using cystine-loaded
proximal tubular epithelial cells have demonstrated depletion
of free phosphate and defective ATP production and
inhibition of Naþ -dependent transporters.4,13,14 It has been
Figure 3 | High-power image of multinucleated visceral
epithelial cell (arrow) (PAS reaction; original magnification
 60).
Figure 4 | Interstitial histiocytes (brown stain) displaying
cytoplasmic clefts and inclusions (CD68 immunoperoxidase
stain; original magnification  60).
Figure 5 | Interstitial cells display cytoplasmic clear clefts
consistent with crystalline inclusions (toluidine blue
stain; original magnification  100).
Figure 6 | Interstitial cells containing multiple clear, elongated,
needle-shaped and rhomboid cytoplasmic inclusions
(electron photomicrograph; original magnification  3000).
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suggested that abnormal proximal tubular Naþ /Kþ ATPase
function due to ATP depletion might lead to increased distal
tubular sodium delivery and Bartter’s syndrome in some
cystinosis patients.5
The diagnosis of cystinosis is confirmed by demonstrating
markedly elevated cystine levels in peripheral blood leuko-
cytes.1 Detection of corneal crystals by slit-lamp examination
is virtually diagnostic of cystinosis in the setting of childhood
Fanconi’s syndrome because these crystals are not seen with
other genetic causes, such as tyrosinemia, galactosemia,
hereditary fructose intolerance, and hepatorenal glycogenosis
(Fanconi–Bickel syndrome), or with acquired causes of
Fanconi’s syndrome, such as lead poisoning. However,
corneal crystals may not develop for several years, and
therefore this finding is not sensitive for early diagnosis.
Genetic testing reveals that the majority of European patients
with cystinosis have a homozygous 57-kb deletion of the first
10 exons of the CTNS gene, consistent with a founder
effect.15,16 However, over 50 different mutations have been
linked to cystinosis and therefore genetic testing for cystinosis
is generally not practicable, except in families known to have
the 57-kb deletion.1 The association of cystinosis with fair
hair and blue eyes described in many reported cases likely
reflects the occurrence of founder mutations in the Northern
European population several hundred years ago,1 rather than
any direct pathogenic relationship to pigmentation, as
cystinosis has also been reported in individuals of African
descent who do not show these physical characteristics.
The renal pathologic findings in infantile cystinosis consist
of a chronic tubulo-interstitial nephropathy, with character-
istic findings of multinucleated podocytes and intracellular
crystalline inclusions in interstitial histiocytes.9 There may be
an increased number of immature glomeruli.17 Microdissec-
tion studies of isolated nephrons have demonstrated a
characteristic ‘swan-neck’ deformity (due to selective tubular
atrophy involving the first part of the proximal tubule) that
appears after 6 months but may not be present earlier,
suggesting that this lesion is acquired rather than congeni-
tal.17 The ‘swan-neck lesion’ may be preceded by the presence
of small intracellular crystals, consistent with cystine, within
tubular epithelial cells.17 However, the ‘swan-neck lesion’
reportedly also occurs with other causes of Fanconi’s
syndrome and is not detectable by routine light microscopic
examination, limiting its diagnostic utility. Because cystine
crystals are water-soluble, these are not retained in tissue
sections following routine histologic preparation with aqu-
eous solutions.18 The cystine crystals are birefringent under
polarized light in alcohol-fixed tissue or in unfixed frozen
tissue. In our case, crystals were not detectable under
polarized light microscopy in cryosections because the frozen
tissue had been placed in Zeus fixative prior to freezing. In
toluidine blue-stained sections of epoxy resin-embedded
tissue, the presence of crystals can be inferred by the
appearance of needle-shaped or rhomboid intracytoplasmic
clefts. These inclusions are most numerous in interstitial
CD68þ histiocytes,9 as shown in the present case, but have
also been described in glomerular epithelial cells and tubular
epithelial cells.17–19 In the present case, the absence of
crystalline inclusions in epithelial cells may reflect the
advanced chronic injury, as no nonsclerotic glomeruli were
available for ultrastructural examination. Spear et al.18
described the presence of distinctive ‘dark cells’ in plastic-
embedded sections prepared for electron microscopy, pro-
bably due to a reaction of osmium tetroxide with intracellular
cystine, but these were not seen in the present case.18
The finding of numerous multinucleated podocytes may
be the most characteristic pathologic finding in nephropathic
cystinosis, as these cells only rarely occur in other
conditions.9,18,20 However, these cells are not seen in sclerotic
glomeruli, hence their absence in cases of severe chronic renal
disease does not exclude a diagnosis of cystinosis. We also
identified multinucleated cells lining Bowman’s capsule, but
whether these cells correspond to the recently described
‘parietal podocytes’ is unclear.21 Podocytes have limited
potential for cell division (with the notable exception of
collapsing variant focal segmental glomerulosclerosis, and
some cases of crescentic glomerulonephritis) and multi-
nucleated podocytes were detected only in rare glomeruli in 6
of 164 renal biopsies of diverse renal disease where these were
specifically sought.20 The lack of CD68 staining in the present
case, and in one other case report,9 provides evidence against
a histiocytic origin. The pathogenesis of multinucleated
podocytes probably involves aberrant nuclear division with-
out accompanying cytokinesis in injured podocytes, a finding
previously described in some patients with focal segmental
glomerulosclerosis.20 It was the observation of distinctive
multinucleated podocytes, together with the findings of
intracellular clefts in interstitial cells, that led to a pathologic
diagnosis of nephropathic cystinosis in the present case.
Table 1 | Clinical manifestations of infantile nephropathic
cystinosis (adapted from Gahl et al.1)
At presentation
Common
Failure to thrive
Polydipsia and polyuria
Fanconi’s syndrome
Vitamin D-resistant rickets
Progressive renal failure
Photophobia
Hypothyroidism
Uncommona
Bartter’s syndrome
Nephrotic syndrome
Diabetes insipidus
Post-renal transplantation
Dysphagia
Myopathy
Exocrine pancreatic insufficiency
Diabetes mellitus
CNS deterioration
Primary hypogonadism
aMay be transient and coexist with common manifestations.
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The differential diagnosis of intracellular inclusions in
renal biopsy specimens includes hereditary disorders of
peroxisomal function, such as Refsum disease, Zellweger’s
syndrome, and primary hyperoxaluria, glycogen storage
disease (for example, galactosemia), and hereditary lipid
storage disorders, such as Fabry disease, mucolipidopsis, and
Gaucher disease. In older individuals, the differential
diagnosis is broader and includes secondary hyperoxaluria
(such as due to ethylene glycol ingestion, enteric disease,
vitamin C intoxication, or excess ingestion of oxalate-
containing foods) and dysproteinemia, which may manifest
as crystalline monoclonal light chain inclusions in tubular
epithelial cells, glomerular epithelial cells, or interstitial
histiocytes. Unlike cystine crystals, oxalate crystals display
birefringence under polarized light in formalin-fixed paraf-
fin-embedded tissue sections. Monoclonal light chain crystal-
line inclusions are detectable by routine immunofluorescence
microscopy in frozen tissue sections, but pronase digestion of
formalin-fixed tissue sections may be a more sensitive
technique (due to antigen retrieval).
The management and treatment of infantile nephropathic
cystinosis involves supportive therapy to maintain fluid
balance and replace electrolyte losses in the initial stage. Early
recognition of the diagnosis and specific treatment with oral
cysteamine (a cystine-depleting agent) may delay the onset of
renal failure and other organ involvement, including thyroid
disease.1 Cysteamine eye-drops may alleviate visual symp-
toms by dissolving the corneal cystine crystals. Renal
transplantation is associated with increased survival in
cystinosis patients who develop end-stage renal disease. Of
note, cystine accumulation has been reported in the
transplanted kidney but, to date, renal clinical manifestations
of cystinosis have not.22 However, extrarenal clinical
manifestations of cystinosis may continue to occur (Table 1).
With worsening renal failure, signs of Fanconi’s syndrome
may diminish in cystinosis patients, and heavy proteinuria
due to hyperfiltration in remnant glomeruli may occur.9
While we cannot fully exclude the possibility that our patient
may have had transient full Fanconi’s syndrome prior to her
initial presentation, this case emphasizes that the presentation
of nephropathic cystinosis may not fulfill all criteria for either
Fanconi’s syndrome or Bartter’s syndrome, and may present
with incomplete and mixed features of both syndromes. A high
index of clinical suspicion is needed for diagnosis of
nephropathic cystinosis in these children, as early initiation
of therapy with cysteamine may slow the rate of disease
progression. Awareness of the characteristic pathologic findings
of multinucleated podocytes and crystal-containing interstitial
cells may suggest the correct diagnosis in subjects who present
with atypical clinical features.
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